Actively Recruiting
Light Therapy in Parkinson's Disease
Led by Second Affiliated Hospital of Soochow University · Updated on 2025-02-12
50
Participants Needed
1
Research Sites
245 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this randomized controlled trial (RCT) is to clarify the effect of bright light therapy on motor symptoms and sleep disorders in patients with Parkinson's disease.
CONDITIONS
Official Title
Light Therapy in Parkinson's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with Parkinson's disease according to MDS criteria, with symptoms corresponding to Hoehn and Yahr stages 2-3
- Stable Parkinson's disease medication for at least one month
- Signed clinical informed consent and agreed not to change medications during the study and follow-up
You will not qualify if you...
- Using hypnotic or stimulating drugs
- Using antidepressants unless on a stable dose for more than three months
- Visual impairments such as cataract, glaucoma, or blindness
- Cognitive impairment with MMSE score below 24
- Uncontrollable hallucinations or mental illnesses
- Having sleep phase delay or advance syndrome, shift work, jet lag, or similar conditions
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Neurology, Second Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China, 215004
Actively Recruiting
Research Team
C
Chun-Feng Liu, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here